• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Q1 sales on the rise for corneal implants

Article

Des Plaines, IL-Sales of corneal implants (Intacs, Addition Technology Inc.) for the treatment of keratoconus and myopia increased 75% in the first quarter of 2006 compared with the same quarter in 2005, according to the manufacturer. Compared with Q4 2005, corneal implants sales increased 12%.

Des Plaines, IL-Sales of corneal implants (Intacs, Addition Technology Inc.) for the treatment of keratoconus and myopia increased 75% in the first quarter of 2006 compared with the same quarter in 2005, according to the manufacturer. Compared with Q4 2005, corneal implants sales increased 12%.

This marks the 12th consecutive quarter of double-digit growth for Addition Technology in the United States and international markets, the company said in a prepared statement. Addition Technology attributes this growth to an increased number of corneal surgeons providing the corneal implants as a treatment alternative for keratoconus.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.